HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyoshi Hasegawa Selected Research

Neoplasms, Cystic, Mucinous, and Serous

1/2024Outcomes after distal pancreatectomy with or without splenectomy for intraductal papillary mucinous neoplasm: international multicentre cohort study.
1/2021ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms.
11/2018Usefulness of indocyanine green-fluorescence imaging for real-time visualization of pancreas neuroendocrine tumor and cystic neoplasm.
8/2014Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyoshi Hasegawa Research Topics

Disease

117Neoplasms (Cancer)
04/2024 - 03/2002
81Hepatocellular Carcinoma (Hepatoma)
02/2024 - 01/2003
61Neoplasm Metastasis (Metastasis)
04/2024 - 02/2003
19Fibrosis (Cirrhosis)
11/2023 - 02/2003
15Hepatitis B
03/2023 - 01/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 12/2009
12Cholangiocarcinoma
02/2024 - 12/2009
12Liver Neoplasms (Liver Cancer)
03/2023 - 06/2009
12Infections
10/2022 - 01/2002
12Hepatitis
01/2016 - 01/2002
11Endometrial Neoplasms (Endometrial Cancer)
01/2020 - 05/2005
9Pathologic Constriction (Stenosis)
02/2024 - 04/2003
9Liver Failure
11/2023 - 09/2014
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2012
9Carcinoma (Carcinomatosis)
01/2021 - 03/2003
8End Stage Liver Disease
04/2024 - 12/2011
8Adenocarcinoma
01/2024 - 09/2010
8Hemorrhage
06/2022 - 02/2015
7Portal Hypertension
11/2023 - 06/2008
7Liver Diseases (Liver Disease)
05/2022 - 01/2002
7Hepatitis C
10/2017 - 01/2009
6Lymphatic Metastasis
01/2024 - 11/2007
6Thrombosis (Thrombus)
11/2023 - 01/2015
6Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 01/2011
5Acute Liver Failure (Fulminant Hepatic Failure)
04/2024 - 01/2002
5Body Weight (Weight, Body)
08/2023 - 08/2014
5Carcinogenesis
03/2023 - 06/2011
5Ascites
08/2019 - 01/2009
5Massive Hepatic Necrosis
09/2004 - 01/2002
4Neoplasms, Cystic, Mucinous, and Serous
01/2024 - 08/2014
4Pancreatic Fistula (Pancreatic Fistulas)
11/2023 - 07/2008
4Inflammation (Inflammations)
01/2022 - 01/2016
4Hypertrophy
06/2020 - 03/2006
4Disease Progression
12/2018 - 09/2002
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
09/2014 - 07/2005
4Chronic Hepatitis B
07/2003 - 03/2002
3Hemophilia A (Haemophilia)
01/2023 - 03/2016
3Coinfection
01/2023 - 07/2003
3Bacterial Infections (Bacterial Infection)
05/2022 - 05/2016
3Fistula
01/2022 - 07/2008
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 03/2015
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2009
3Pain (Aches)
01/2021 - 08/2013

Drug/Important Bio-Agent (IBA)

20Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2023 - 06/2009
14Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2003
12Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2002
11Messenger RNA (mRNA)IBA
01/2022 - 11/2004
10EnzymesIBA
12/2023 - 06/2005
9Tumor Biomarkers (Tumor Markers)IBA
02/2024 - 05/2008
8DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
7BilirubinIBA
05/2022 - 01/2002
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 02/2003
6AlbuminsIBA
08/2019 - 08/2009
6Prothrombin (Factor II)IBA
10/2015 - 01/2002
6acarboxyprothrombin (PIVKA)IBA
04/2014 - 08/2004
5MucinsIBA
01/2023 - 12/2009
5SteroidsIBA
01/2017 - 01/2002
4AmylasesFDA Link
11/2023 - 11/2014
4Bevacizumab (Avastin)FDA Link
08/2023 - 08/2017
4Cetuximab (Erbitux)FDA Link
06/2022 - 07/2014
4TegafurIBA
10/2021 - 10/2006
4UracilIBA
10/2021 - 10/2006
4AntibodiesIBA
05/2021 - 03/2013
4Etodolac (Lodine)FDA LinkGeneric
12/2013 - 05/2005
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2013 - 05/2005
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2009 - 01/2002
4Lamivudine (Epivir)FDA Link
07/2003 - 03/2002
3AntigensIBA
01/2023 - 12/2009
3lenvatinibIBA
01/2023 - 02/2022
3Cadherins (E-Cadherin)IBA
10/2022 - 01/2016
3Hemostatics (Antihemorrhagics)IBA
06/2022 - 02/2015
3sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 01/2016
3ChromatinIBA
01/2022 - 01/2015
3Leucovorin (Folinic Acid)FDA Link
10/2021 - 02/2014
3Capsules (Microcapsules)IBA
04/2021 - 03/2018
3AcidsIBA
12/2020 - 08/2005
3Serum AlbuminIBA
06/2020 - 01/2019

Therapy/Procedure

62Liver Transplantation
04/2024 - 07/2003
58Hepatectomy
11/2023 - 02/2003
36Therapeutics
04/2024 - 01/2002
26Drug Therapy (Chemotherapy)
11/2023 - 02/2009
11Pancreaticoduodenectomy
03/2022 - 04/2003
10Adjuvant Chemotherapy
01/2024 - 04/2007
9Transplantation
07/2022 - 11/2006
8Operative Surgical Procedures
01/2024 - 08/2014
8Radiofrequency Ablation
10/2023 - 07/2010
6Blood Transfusion (Blood Transfusions)
11/2023 - 12/2007
5Pancreatectomy
01/2024 - 07/2008
5Stents
01/2024 - 01/2019
5Lasers (Laser)
11/2023 - 01/2014
4Photochemotherapy (Photodynamic Therapy)
02/2021 - 01/2014
3Splenectomy
01/2024 - 12/2013
3Segmental Mastectomy (Lumpectomy)
10/2023 - 03/2016
3Operative Time
07/2023 - 11/2016
3Neoadjuvant Therapy
09/2022 - 05/2018
3Laparoscopic Cholecystectomy
01/2022 - 07/2003
3Laparotomy
03/2021 - 01/2017
3Aftercare (After-Treatment)
01/2021 - 10/2016
3Metastasectomy
10/2020 - 09/2012
3Renal Dialysis (Hemodialysis)
06/2020 - 10/2017